Pictet Asset Management Holding SA
Position in DNLI — Denali Therapeutics Inc.
CIK 1993888
CAROUGE, V8
Position in DNLI
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$71,789,818
+$22,659,610 QoQ
Shares Held
2,791,206
+9.1% QoQ
Ownership
1.75%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#19
of 290 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pictet Asset Management Holding SA holds $3,949,485,019 across 130 Biotechnology names. DNLI ranks #20 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
539,255 | $267,864,136 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,014,894 | $190,069,348 | |
| 3 | ARGX |
Argenx SE
|
198,282 | $183,960,091 | |
| 4 | INSM |
INSMED Inc
|
1,220,353 | $130,114,036 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,596,998 | $126,625,971 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
3,468,340 | $122,744,552 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,448,126 | $107,856,424 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
957,785 | $106,342,868 |
All Filings in DNLI
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $71,789,818 | 2,791,206 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $49,130,208 | 2,558,865 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $21,943,573 | 1,329,108 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $7,247,832 | 499,162 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $5,807,416 | 415,112 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,676,122 | 343,959 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $394,475 | 19,356 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $482,101 | 16,550 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $320,343 | 13,796 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $283,093 | 13,796 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,425,618 | 439,218 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $12,161,364 | 589,499 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||